(1)
Ali , M. M. .; Mahmood, N. M. A. The Use of Cyclin-Dependent Tyrosine Kinase 4 6 (CDK4 6) Inhibitors in Breast Cancer. Al-Rafidain J Med Sci 2022, 3, 30-35.